• 1. 

    Rosenbaum AJ & DiPreta JA: Classifications in brief: Eichenholtz classification of Charcot arthropathy. Clin Orthop 473 : 1168, 2015.

  • 2. 

    Rogers LC , Frykberg RG & Armstrong DG et al.: The Charcot foot in diabetes. Diabetes Care 34 : 2123, 2011.

  • 3. 

    Salini D , Harish K & Minnie P et al.: Prevalence of Charcot arthropathy in type 2 diabetes patients aged over 50 years with severe peripheral neuropathy: a retrospective study in a tertiary care South Indian Hospital. Indian J Endocrinol Metab 22 : 107, 2018.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4. 

    Fabrin J , Larsen K & Holstein PE: Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care 23 : 796, 2000.

  • 5. 

    Lavery LA , Armstrong DG & Wunderlich RP et al.: Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care 26 : 1435, 2003.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6. 

    Sinha S , Munichoodappa CS & Kozak GP: Neuro-arthropathy (Charcot joints) in diabetes mellitus (clinical study of 101 cases). Medicine (Baltimore) 51 : 191, 1972.

  • 7. 

    Sohn M-W , Lee TA & Stuck RM et al.: Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone. Diabetes Care 32 : 816, 2009.

  • 8. 

    Pinzur MS & Evans A: Health-related quality of life in patients with Charcot foot. Am J Orthop Belle Mead NJ 32 : 492, 2003.

  • 9. 

    Zheng Y , Ley SH & Hu FB: Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14 : 88, 2018.

  • 10. 

    Brodsky JW : “The Diabetic Foot,” in Surgery of the Foot and Ankle, ed by Coughlin, MJ, Mann, RA & Saltzman, CL p 1281, Mosby-Elsevier, St Louis, 2006.

  • 11. 

    Al-Rubeaan K , Al-Manaa HA & Khoja TA et al.: Epidemiology of abnormal glucose metabolism in a country facing its epidemic: SAUDI-DM study. J Diabetes 7 : 622, 2015.

  • 12. 

    Al-Rubeaan KA , Youssef AM & Subhani SN et al.: A Web-based interactive diabetes registry for health care management and planning in Saudi Arabia. J Med Internet Res 15 : e202, 2013.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13. 

    Akbar DH , Mira SA & Zawawi TH et al.: Subclinical diabetic neuropathy: a common complication in Saudi diabetics. Saudi Med J 21 : 433, 2000.

  • 14. 

    El-Asrar AM , Al-Rubeaan KA & Al-Amro SA et al.: Risk factors for diabetic retinopathy among Saudi diabetics. Int Ophthalmol 22 : 155, 1998.

  • 15. 

    Alwakeel JS , Al-Suwaida A & Isnani AC et al.: Concomitant macro and microvascular complications in diabetic nephropathy. Saudi J Kidney Dis Transpl 20 : 402, 2009.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16. 

    Alzahrani HA , Wang D & Bakhotmah BA et al.: Risk factors for peripheral artery disease among patients with diabetes in Saudi Arabia. Vasc Med Lond Engl 19 : 103, 2014.

  • 17. 

    Al-Rubeaan K , Al Derwish M & Ouizi S et al.: Diabetic foot complications and their risk factors from a large retrospective cohort study. PLoS One 10 : e0124446, 2015.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18. 

    Donegan R , Sumpio B & Blume PA: Charcot foot and ankle with osteomyelitis. Diabet Foot Ankle 4: 2013.

  • 19. 

    Thewjitcharoen Y , Sripatpong J & Parksook W et al.: Salient features and outcomes of Charcot foot: an often-overlooked diabetic complication: a 17-year-experience at a diabetic center in Bangkok. J Clin Transl Endocrinol 11 : 1, 2018.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20. 

    Al-Wahbi AM: The diabetic foot in the Arab world. Saudi Med J 27 : 147, 2006.

  • 21. 

    Chisholm KA & Gilchrist JM: The Charcot joint: a modern neurologic perspective. J Clin Neuromuscul Dis 13 : 1, 2011.

  • 22. 

    Ferreira RC , Silva APS & Costa MT et al.: Epidemiological aspects of foot and ankle injury in the diabetic patient. Acta Ortop Bras 18 : 135, 2010.

  • 23. 

    Leung HB , Ho YC & Wong WC: Charcot foot in a Hong Kong Chinese diabetic population. Hong Kong Med J 15 : 191, 2009.

  • 24. 

    Fauzi AA , Chung TY & Latif LA: Risk factors of diabetic foot Charcot arthropathy: a case-control study at a Malaysian tertiary care centre. Singapore Med J 57 : 198, 2016.

  • 25. 

    Kensarah AMA , Zaidi NH & Noorwali A et al.: Evaluation of Charcot neuroarthropathy in diabetic foot disease patients at tertiary hospital. Surg Sci 07 : 250, 2016.

  • 26. 

    Kaynak G , Birsel O & Güven MF et al.: An overview of the Charcot foot pathophysiology. Diabet Foot Ankle 4: 2013.

  • 27. 

    Ivers RQ , Cumming RG & Mitchell P et al.: Diabetes and risk of fracture: the Blue Mountains Eye Study. Diabetes Care 24 : 1198, 2001.

  • 28. 

    Hordon LD: Diabetic bone disease and Charcot joints: a review. J Diabetes Nurs 21 : 50, 2017.

  • 29. 

    Barreto de Medeiros Nóbrega M , Aras R & Netto EM et al.: Risk factors for Charcot foot. Arch Endocrinol Metab 59 : 226, 2015.

  • 30. 

    Chantelau E , Richter A & Ghassem-Zadeh N et al.: “Silent” bone stress injuries in the feet of diabetic patients with polyneuropathy: a report on 12 cases. Arch Orthop Trauma Surg 127 : 171, 2007.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31. 

    Gupta R: A short history of neuropathic arthropathy. Clin Orthop Relat Res 296 : 43, 1993.

  • 32. 

    Mueller MJ , Minor SD & Diamond JE et al.: Relationship of foot deformity to ulcer location in patients with diabetes mellitus. Phys Ther 70 : 356, 1990.

  • 33. 

    Rajbhandari SM , Jenkins RC & Davies C et al.: Charcot neuroarthropathy in diabetes mellitus. Diabetologia 45 : 1085, 2002.

  • 34. 

    Buzaid N & Nagem F: Characteristics of diabetic foot disease and risk factors in Benghazi, Libya. Ibnosina J Med Biomed Sci 10 : 165, 2018.

Characteristics of Patients with Charcot's Arthropathy and its Complications in the Saudi Diabetic Population: A Cross-Sectional Study

Khalid Al-Rubeaan
Search for other papers by Khalid Al-Rubeaan in
Current site
Google Scholar
PubMed
Close
 FRCPC
,
Khaled H. Aburisheh
Search for other papers by Khaled H. Aburisheh in
Current site
Google Scholar
PubMed
Close
 MRCP
,
Yousuf Al Farsi
Search for other papers by Yousuf Al Farsi in
Current site
Google Scholar
PubMed
Close
 MD
,
Mohammad Al Derwish
Search for other papers by Mohammad Al Derwish in
Current site
Google Scholar
PubMed
Close
 BN
,
Samir Ouizi
Search for other papers by Samir Ouizi in
Current site
Google Scholar
PubMed
Close
 Bsc, MPodMed
,
Fahad Alblaihi
Search for other papers by Fahad Alblaihi in
Current site
Google Scholar
PubMed
Close
 MBBS, ABFM
,
Ali Jaber ALHagawy
Search for other papers by Ali Jaber ALHagawy in
Current site
Google Scholar
PubMed
Close
 MBBS, ABFM
,
Rakan Khalid AlSalem
Search for other papers by Rakan Khalid AlSalem in
Current site
Google Scholar
PubMed
Close
 MBBS
,
Musab Abdualaziz Alageel
Search for other papers by Musab Abdualaziz Alageel in
Current site
Google Scholar
PubMed
Close
 MBBS
,
Mona Heide Toledo
Search for other papers by Mona Heide Toledo in
Current site
Google Scholar
PubMed
Close
 BN
, and
Amira M. Youssef
Search for other papers by Amira M. Youssef in
Current site
Google Scholar
PubMed
Close
 BPharm

Background

Charcot's arthropathy (CA) is a destructive rare complication of diabetes, and its diagnosis remains challenging for foot specialists and surgeons. We aimed to assess the clinical presentation and characteristics of CA and the frequencies of its various types.

Methods

This cross-sectional study was conducted from January 1, 2007, to December 31, 2016, and included 149 adults with diabetes diagnosed as having CA. Cases of CA were classified based on the Brodsky anatomical classification into five types according to location and involved joints.

Results

The mean ± SD age of the studied cohort was 56.7 ± 11 years, with a mean ± SD diabetes duration of 21.2 ± 7.0 years. The CA cohort had poorly controlled diabetes and a high rate of neuropathy and retinopathy. The most frequent type of CA was type 4, with multiple regions involved at a rate of 56.4%, followed by type 1, with midfoot involvement at 34.5%. A total of 47.7% of the patients had bilateral CA. Complications affected 220 limbs, of which 67.7% had foot ulceration. With respect to foot deformity, hammertoe affected all of the patients; hallux valgus, 59.5%; and flatfoot, 21.8%.

Conclusions

There is a high rate of bilateral CA, mainly type 4, which could be attributed to cultural habits in Saudi Arabia, including footwear. This finding warrants increasing awareness of the importance of maintaining proper footwear to avoid such complications. Implementation of preventive measures for CA is urgently needed.

University Diabetes Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Diabetic Foot Unit, University Diabetes Center, King Saud University, Riyadh, Saudi Arabia.

College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Strategic Center for Diabetes Research, Riyadh, Saudi Arabia.

Corresponding author: Khalid Al-Rubeaan, FRCPC, King Saud University, PO Box 18397, Riyadh 11415, Saudi Arabia. (E-mail: rubeaan@gmail.com)
Save